Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Makris

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Circulation|February 1, 1995
Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study GroupI Crozier, H Ikram, N Awan, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|July 1, 1995
Antihypertensive efficacy and tolerability of once daily losartan potassium compared with captopril in patients with mild to moderate essential hypertensionJ M Mallion, D C Bradstreet, L Makris, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 28, 2013
Developmental neurotoxicity of engineered nanomaterials: identifying research needs to support human health risk assessmentChristina M Powers, Ambuja S Bale, Andrew D Kraft, et al.
Toxicology Letters|May 18, 2019
The evaluation of inhalation studies for exposure quality: A case study with formaldehydeJohn E Whalan, John Stanek, George Woodall, et al.
Reproductive Toxicology (Elmsford, N.Y.)|May 6, 2018
The urgency for optimization and harmonization of thyroid hormone analyses and their interpretation in developmental and reproductive toxicology studiesManon Beekhuijzen, Steffen Schneider, Narinder Barraclough, et al.
Birth Defects Research|March 1, 2023
Society for Birth Defects Research and Prevention 2022-2027 strategic planSusan L Makris, Bruce K Beyer, Anthony DeLise, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 1, 2004
A proposed testing framework for developmental immunotoxicology (DIT)Michael P Holsapple, Leigh Ann Burns-Naas, Kenneth L Hastings, et al.
Regulatory Toxicology and Pharmacology : RTP|June 17, 2024
Review of dose setting for the extended one-generation reproductive toxicity studies (OECD TG 443): Considerations on ECHA's dose level selection recommendationsManon Beekhuijzen, Emily Richmond, Jason Manton, et al.
American Heart Journal|September 1, 1994
First-dose effects of enalapril 2.5 mg and captopril 6.25 mg in patients with heart failure: a double-blind, randomized, multicenter study. The Enalapril-Captopril InvestigatorsR M Lang, R DiBianco, G T Broderick, et al.
Journal of the American College of Cardiology|October 8, 1997
Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study InvestigatorsR M Lang, U Elkayam, L G Yellen, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Circulation|February 1, 1995
Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study GroupI Crozier, H Ikram, N Awan, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|July 1, 1995
Antihypertensive efficacy and tolerability of once daily losartan potassium compared with captopril in patients with mild to moderate essential hypertensionJ M Mallion, D C Bradstreet, L Makris, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 28, 2013
Developmental neurotoxicity of engineered nanomaterials: identifying research needs to support human health risk assessmentChristina M Powers, Ambuja S Bale, Andrew D Kraft, et al.
Toxicology Letters|May 18, 2019
The evaluation of inhalation studies for exposure quality: A case study with formaldehydeJohn E Whalan, John Stanek, George Woodall, et al.
Reproductive Toxicology (Elmsford, N.Y.)|May 6, 2018
The urgency for optimization and harmonization of thyroid hormone analyses and their interpretation in developmental and reproductive toxicology studiesManon Beekhuijzen, Steffen Schneider, Narinder Barraclough, et al.
Birth Defects Research|March 1, 2023
Society for Birth Defects Research and Prevention 2022-2027 strategic planSusan L Makris, Bruce K Beyer, Anthony DeLise, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 1, 2004
A proposed testing framework for developmental immunotoxicology (DIT)Michael P Holsapple, Leigh Ann Burns-Naas, Kenneth L Hastings, et al.
Regulatory Toxicology and Pharmacology : RTP|June 17, 2024
Review of dose setting for the extended one-generation reproductive toxicity studies (OECD TG 443): Considerations on ECHA's dose level selection recommendationsManon Beekhuijzen, Emily Richmond, Jason Manton, et al.
American Heart Journal|September 1, 1994
First-dose effects of enalapril 2.5 mg and captopril 6.25 mg in patients with heart failure: a double-blind, randomized, multicenter study. The Enalapril-Captopril InvestigatorsR M Lang, R DiBianco, G T Broderick, et al.
Journal of the American College of Cardiology|October 8, 1997
Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study InvestigatorsR M Lang, U Elkayam, L G Yellen, et al.
Pageof 8